Compared with placebo, probiotics reduced the Movement Disorders Society-Unified Parkinson’s Disease Rating Scale scores, high-sensitivity C-reactive protein, malondialdehyde and insulin levels, insulin resistance, enhanced glutathione levels, and insulin sensitivity (Tamtaji et al., 2019). This evidence concerns the gene INS and movement disorder.